Sanderson; Adam Jan
Patent Applications and Registrations
Patent applications and USPTO patent grants for Sanderson; Adam Jan.The latest application filed is for "cgrp receptor antagonists".
- Sanderson; Adam Jan - Camberley GB
- Sanderson; Adam Jan - Surrey GB
- Sanderson; Adam Jan - Baskingstoke GB
- Sanderson; Adam Jan - Basingstoke GB
| Patent | Date |
|---|---|
| CGRP receptor antagonists Grant 11,066,386 - Coates , et al. July 20, 2 | 2021-07-20 |
| Cgrp Receptor Antagonists App 20200181111 - Coates; David Andrew ; et al. | 2020-06-11 |
| Selective BACE1 inhibitors Grant 10,011,610 - Remick , et al. July 3, 2 | 2018-07-03 |
| Selective BACE1 inhibitors Grant 9,938,266 - Sanderson April 10, 2 | 2018-04-10 |
| Selective Bace1 Inhibitors App 20180030044 - Sanderson; Adam Jan | 2018-02-01 |
| Selective BACE1 Inhibitors App 20160318953 - Remick; David Michael ; et al. | 2016-11-03 |
| Purine compounds Grant 8,759,360 - Sanderson , et al. June 24, 2 | 2014-06-24 |
| Substituted [(5H-pyrrolo[2,1-c][1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylp- ropanoic acid compounds as dual activity H1 inverse agonists/5-HT.sub.2A antagonists Grant 8,314,092 - Camp , et al. November 20, 2 | 2012-11-20 |
| SUBSTITUTED [(5H-PYRROLO[2,1-c][1,4]BENZODIAZEPIN-11-YL)PIPERAZIN-1-YL]-2,2-DIMETHYLP- ROPANOIC ACID COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS App 20120202797 - CAMP; Anne Marie ; et al. | 2012-08-09 |
| Purine Compounds App 20110245255 - SANDERSON; Adam Jan ; et al. | 2011-10-06 |
| Aza-cyclic compounds as modulators of acetylcholine receptors Grant 7,408,067 - Astles , et al. August 5, 2 | 2008-08-05 |
| Modulators of acetylcholine receptors App 20070054912 - Astles; Peter Charles ; et al. | 2007-03-08 |
| Modulators of acetylcholine receptors Grant 7,148,236 - Astles , et al. December 12, 2 | 2006-12-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 